Brighthouse Financial (BHF) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
23 Feb, 2026Executive summary
Fourth quarter 2025 net income available to shareholders was $112 million ($1.93 per diluted share), down from $646 million ($10.79 per diluted share) in Q4 2024, reflecting anticipated volatility due to hedge target and GAAP reserve differences.
Full year 2025 net income available to shareholders was $331 million ($5.71 per diluted share), up from $286 million ($4.64 per diluted share) in 2024.
Adjusted earnings, less notable items, for Q4 2025 were $227 million ($3.93 per diluted share), compared to $352 million ($5.88 per diluted share) in Q4 2024.
Record full year annuity sales of $10.3 billion, driven by Shield Level Annuities; record life sales of $143 million, led by SmartCare.
Financial highlights
Q4 2025 adjusted earnings were $214 million ($3.70 per diluted share), down from $304 million ($5.07 per diluted share) in Q4 2024.
Full year 2025 adjusted earnings, less notable items, were $931 million ($16.07 per diluted share), down from $1,209 million ($19.63 per diluted share) in 2024.
Book value at year-end 2025 was $5.1 billion ($88.66 per share); book value excluding AOCI was $8.8 billion ($153.89 per share).
Corporate expenses for Q4 2025 were $234 million, up from $210 million in Q4 2024; full year corporate expenses were $880 million, up from $820 million in 2024.
Outlook and guidance
Management expects continued volatility in net income due to market performance and differences between hedge targets and GAAP reserves.
Latest events from Brighthouse Financial
- Merger and related proposals were approved by stockholders as recommended by the board.BHF
EGM 202612 Feb 2026 - Shareholders to vote on merger amid litigation and board's unanimous support.BHF
Proxy Filing4 Feb 2026 - Adjusted earnings reached $346M with record life sales, but statutory capital and RBC ratio declined.BHF
Q2 20242 Feb 2026 - Adjusted earnings surged on actuarial gains, with life sales up 19% and capital actions ongoing.BHF
Q3 202415 Jan 2026 - Shareholders to vote on $70/share cash merger with Aquarian Holdings; board recommends approval.BHF
Proxy Filing7 Jan 2026 - Q4 2024 net income was $646M, with record annuity and life sales and strong capital metrics.BHF
Q4 202426 Dec 2025 - Shareholders to vote on $70.00 per share cash merger, with board unanimous in recommending approval.BHF
Proxy Filing23 Dec 2025 - Preliminary proxy outlines annual meeting proposals and board governance for shareholder vote.BHF
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, auditor, executive pay, and updated incentive plan amid strong strategic progress.BHF
Proxy Filing1 Dec 2025